Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Pulmonary thromboembolism is a frequent complication of cancer; in some cases, it is diagnosed occasionally during diagnostic examinations as part of the regular follow-up of the disease. Not all patients diagnosed with thromboembolism present symptoms; therefore, after appropriate investigations during observation in the emergency room and/or a short hospitalisation in Emergency Medicine, they could be discharged home, avoiding lengthy hospitalisations that would have a considerable impact on their health and psychological condition. The goal of this observational study is to compare the efficacy of several assessment scales for use by physicians to identify patients at low risk of developing serious complications of pulmonary embolism within 30 days of diagnosis, in order to be able to identify a group of low-risk patients who could be discharged early from the emergency department/emergency medicine safely. What does participation in this study entail compared to the normal care you receive and what are your responsibilities as a participant? At the time of patient enrolment in the emergency room/emergency medicine, the data necessary for the calculation of 6 scoring systems will be collected, which will take approximately 5 minutes. The patient enrolled in the study will be contacted by telephone in order to assess the state of health; the call will take approximately 1 minute and will take place 30 days after access to the emergency room. Participation in the study does not entail any obligation or restriction, nor will it be charged for.

Who May Be Eligible (Plain English)

Who May Qualify: - Age ≥ 18 years - Diagnosis of pulmonary embolism (symptomatic and/or incidental) - Active onco-haematological disease (disease followed in oncological/haematological and/or metastatic setting) - willing to sign a consent form to the study Who Should NOT Join This Trial: - Patients returning to the Emergency Department for complications related to previously diagnosed pulmonary embolism Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age ≥ 18 years * Diagnosis of pulmonary embolism (symptomatic and/or incidental) * Active onco-haematological disease (disease followed in oncological/haematological and/or metastatic setting) * Informed consent to the study Exclusion Criteria: * Patients returning to the Emergency Department for complications related to previously diagnosed pulmonary embolism

Locations (1)

Eleonora Tubertini
Bologna, Italy